Study Finds Diabetes Medication Reduces Risk Of Death And Heart Disease In People With Arthritis August 12, 2024 (Vancouver) A study conducted by Arthritis Research Canada has revealed that certain diabetes medications, specifically glucagon-like peptide-1 receptor agonists (GLP-1-RAs) like semaglutide (Ozempic), reduced the risk of death and heart attacks in people with immune-mediated inflammatory diseases (IMIDs), such as rheumatoid arthritis, psoriasis, and lupus, who also have type 2 diabetes
Its mechanism focuses on improving insulin resistance and regulating glucose, which doesnt align with the needs of individuals whose pancreas produces little to no insulin
TMABA is then dehydrogenated into gamma-butyrobetaine in an NAD + -dependent reaction, catalyzed by TMABA dehydrogenase
Use features like bookmarks, note taking and highlighting while reading Super Easy GLP-1 High Protein Cookbook for Weight Loss: Protect Muscle, Stop Side Effects, and Lose Weight with Simple, Delicious High-Protein Recipes That Actually Feel Good on GLP-1.
Gabriel Azzini